Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker DGX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 11,717 | $3.0M | 10b5-1 | Nov 9, 2026 | Form 4 ↗ 3 days later · 11,717 shares | Form 144 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 22,105 | $5.6M | 10b5-1 | Nov 3, 2026 | Form 4 ↗ 2 days later · 22,105 shares | Form 144 ↗ |
| Oct 26, 2026 | Gary M. Pfeiffer Director | DGX Quest Diagnostics Incorporated | 1,203 | $292.3K | 10b5-1 | Oct 26, 2026 | Form 4 ↗ 2 days later · 1,203 shares | Form 144 ↗ |
| Sep 1, 2026 | Davis J. E. Officer, Director | DGX Quest Diagnostics Incorporated | 10,000 | $2.4M | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Aug 28, 2026 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 22,677 | $5.5M | 10b5-1 | Aug 28, 2026 | Form 4 ↗ 3 days later · 22,677 shares | Form 144 ↗ |
| Jul 28, 2026 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 1,600 | $376.3K | 10b5-1 | Jul 28, 2026 | Form 4 ↗ 1 day later · 1,600 shares | Form 144 ↗ |
| Jun 4, 2026 | Kuppusamy Karthik Officer | DGX Quest Diagnostics Incorporated | 8,147 | $1.6M | 10b5-1 | Jun 4, 2026 | Form 4 ↗ 4 days later · 8,147 shares | Form 144 ↗ |
| Jun 1, 2026 | Davis J. E. Officer, Director | DGX Quest Diagnostics Incorporated | 10,000 | $1.9M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Mar 5, 2026 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 3,878 | $799.7K | 10b5-1 | Mar 5, 2026 | Form 4 ↗ 1 day later · 3,878 shares | Form 144 ↗ |
| Mar 5, 2026 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 5,558 | $1.1M | 10b5-1 | Mar 5, 2026 | Form 4 ↗ 1 day later · 5,558 shares | Form 144 ↗ |
| Mar 5, 2026 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 2,855 | $588.7K | 10b5-1 | Mar 5, 2026 | Form 4 ↗ 1 day later · 2,855 shares | Form 144 ↗ |
| Mar 3, 2026 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 632 | $131.3K | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 1 day later · 632 shares | Form 144 ↗ |
| Mar 3, 2026 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 526 | $109.3K | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 1 day later · 526 shares | Form 144 ↗ |
| Mar 3, 2026 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 410 | $85.2K | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 1 day later · 410 shares | Form 144 ↗ |
| Mar 2, 2026 | Davis J. E. Officer, Director | DGX Quest Diagnostics Incorporated | 10,000 | $2.1M | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Feb 19, 2026 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 958 | $196.2K | 10b5-1 | Feb 19, 2026 | Form 4 ↗ 1 day later · 958 shares | Form 144 ↗ |
| Feb 19, 2026 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 1,433 | $293.5K | 10b5-1 | Feb 19, 2026 | Form 4 ↗ 1 day later · 1,433 shares | Form 144 ↗ |
| Feb 19, 2026 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 1,111 | $227.6K | 10b5-1 | Feb 19, 2026 | Form 4 ↗ 1 day later · 1,111 shares | Form 144 ↗ |
| Feb 13, 2026 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 26,165 | $5.4M | 10b5-1 | Feb 13, 2026 | Form 4 ↗ 4 days later · 26,165 shares | Form 144 ↗ |
| Feb 10, 2026 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 5,662 | $1.2M | 10b5-1 | Feb 10, 2026 | Form 4 ↗ 2 days later · 5,662 shares | Form 144 ↗ |
| Nov 25, 2025 | Davis J. E. Officer, Director | DGX Quest Diagnostics Incorporated | 55,093 | $10.6M | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 3 days later · 55,093 shares | Form 144 ↗ |
| Nov 25, 2025 | Vicky B. Gregg Director | DGX Quest Diagnostics Incorporated | 1,250 | $239.7K | — | Nov 25, 2025 | Form 4 ↗ 3 days later · 1,250 shares | Form 144 ↗ |
| Nov 18, 2025 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 7,946 | $1.5M | 10b5-1 | Nov 18, 2025 | Form 4 ↗ 2 days later · 7,946 shares | Form 144 ↗ |
| Oct 22, 2025 | Gary M. Pfeiffer Director | DGX Quest Diagnostics Incorporated | 1,482 | $270.3K | — | Oct 22, 2025 | Form 4 ↗ 2 days later · 1,482 shares | Form 144 ↗ |
| Sep 26, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 227 | $42.7K | 10b5-1 | Sep 26, 2025 | Form 4 ↗ 4 days later · 227 shares | Form 144 ↗ |
| Sep 24, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 175 | $32.7K | 10b5-1 | Sep 24, 2025 | Form 4 ↗ 1 day later · 28,463 shares | Form 144 ↗ |
| Sep 23, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 28,288 | $5.3M | 10b5-1 | Sep 23, 2025 | Form 4 ↗ 2 days later · 28,463 shares | Form 144 ↗ |
| Aug 21, 2025 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 1,975 | $365.4K | 10b5-1 | Aug 21, 2025 | Form 4 ↗ 4 days later · 1,975 shares | Form 144 ↗ |
| Aug 19, 2025 | Patrick Plewman Director | DGX Quest Diagnostics Incorporated | 4,532 | $829.4K | 10b5-1 | Aug 19, 2025 | Form 4 ↗ 2 days later · 4,532 shares | Form 144 ↗ |
| Aug 15, 2025 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 72 | $13.0K | 10b5-1 | Aug 15, 2025 | Form 4 ↗ 4 days later · 1,975 shares | Form 144 ↗ |
| Aug 15, 2025 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 1,903 | $342.5K | 10b5-1 | Aug 15, 2025 | Form 4 ↗ 4 days later · 1,975 shares | Form 144 ↗ |
| Aug 6, 2025 | Patrick Plewman Officer | DGX Quest Diagnostics Incorporated | 5,535 | $968.6K | 10b5-1 | Aug 6, 2025 | Form 4 ↗ 2 days later · 5,535 shares | Form 144 ↗ |
| Jul 31, 2025 | Kuppusamy Karthik Officer | DGX Quest Diagnostics Incorporated | 2,210 | $375.7K | 10b5-1 | Jul 31, 2025 | Form 4 ↗ 1 day later · 10,479 shares | Form 144 ↗ |
| Jul 30, 2025 | Kuppusamy Karthik Officer | DGX Quest Diagnostics Incorporated | 8,269 | $1.4M | 10b5-1 | Jul 30, 2025 | Form 4 ↗ 2 days later · 10,479 shares | Form 144 ↗ |
| May 13, 2025 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 874 | $153.2K | 10b5-1 | May 13, 2025 | Form 4 ↗ 1 day later · 1,748 shares | Form 144 ↗ |
| May 12, 2025 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 874 | $153.6K | 10b5-1 | May 12, 2025 | Form 4 ↗ 2 days later · 1,748 shares | Form 144 ↗ |
| Apr 2, 2025 | Davis J. E. Officer, Director | DGX Quest Diagnostics Incorporated | 39,191 | $6.7M | 10b5-1 | Apr 2, 2025 | Form 4 ↗ 2 days later · 39,191 shares | Form 144 ↗ |
| Apr 2, 2025 | Kuppusamy Karthik Officer | DGX Quest Diagnostics Incorporated | 2,555 | $434.4K | 10b5-1 | Apr 2, 2025 | Form 4 ↗ 2 days later · 2,555 shares | Form 144 ↗ |
| Mar 17, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 4,643 | $789.3K | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 2 days later · 4,643 shares | Form 144 ↗ |
| Mar 5, 2025 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 5,370 | $935.1K | 10b5-1 | Mar 5, 2025 | Form 4 ↗ 2 days later · 5,370 shares | Form 144 ↗ |
| Mar 4, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 592 | $104.1K | 10b5-1 | Mar 4, 2025 | Form 4 ↗ 1 day later · 592 shares | Form 144 ↗ |
| Mar 4, 2025 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 716 | $125.9K | 10b5-1 | Mar 4, 2025 | Form 4 ↗ 1 day later · 716 shares | Form 144 ↗ |
| Feb 27, 2025 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 824 | $142.2K | 10b5-1 | Feb 27, 2025 | Form 4 ↗ 1 day later · 824 shares | Form 144 ↗ |
| Feb 27, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 528 | $91.1K | 10b5-1 | Feb 27, 2025 | Form 4 ↗ 1 day later · 528 shares | Form 144 ↗ |
| Feb 20, 2025 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 604 | $103.3K | 10b5-1 | Feb 20, 2025 | Form 4 ↗ 1 day later · 604 shares | Form 144 ↗ |
| Feb 20, 2025 | Catherine T. Doherty Officer | DGX Quest Diagnostics Incorporated | 899 | $153.7K | 10b5-1 | Feb 20, 2025 | Form 4 ↗ 1 day later · 1,434 shares | Form 144 ↗ |
| Feb 5, 2025 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 403 | $66.2K | — | Feb 5, 2025 | Form 4 ↗ 2 days later · 403 shares | Form 144 ↗ |
| Feb 5, 2025 | Vicky B. Gregg Director | DGX Quest Diagnostics Incorporated | 1,250 | $205.7K | — | Feb 5, 2025 | Form 4 ↗ 2 days later · 1,250 shares | Form 144 ↗ |
| Jan 31, 2025 | Mark E. Delaney Officer | DGX Quest Diagnostics Incorporated | 2,615 | $431.1K | — | Jan 31, 2025 | Form 4 ↗ 7 days later · 403 shares | Form 144 ↗ |
| Nov 29, 2024 | Michael E. Prevoznik Officer | DGX Quest Diagnostics Incorporated | 35,146 | $5.7M | 10b5-1 | Nov 29, 2024 | Form 4 ↗ 3 days later · 35,146 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances